Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system

被引:19
作者
Baser, Husniye [1 ]
Topaloglu, Oya [2 ]
Tam, Abbas Ali [2 ]
Evranos, Berna [1 ]
Alkan, Afra [3 ]
Sungu, Nuran [4 ]
Dumlu, Ersin Gurkan [5 ]
Ersoy, Reyhan [2 ]
Cakir, Bekir [2 ]
机构
[1] Ataturk Educ & Res Hosp, Dept Endocrinol & Metab, 1297 Sokak,1-22, TR-06460 Ankara, Turkey
[2] Yildirim Beyazit Univ, Dept Endocrinol & Metab, Fac Med, Ankara, Turkey
[3] Yildirim Beyazit Univ, Dept Biostat, Fac Med, Ankara, Turkey
[4] Yildirim Beyazit Univ, Dept Pathol, Fac Med, Ankara, Turkey
[5] Yildirim Beyazit Univ, Dept Gen Surg, Fac Med, Ankara, Turkey
关键词
Thyrotropin; Thyroid malignancy; Cytology; Bethesda categories; FINE-NEEDLE-ASPIRATION; HORMONE-RECEPTOR; COMMON VARIANTS; CANCER PATIENTS; HIGH PREVALENCE; SERUM TSH; THYROTROPIN; ULTRASOUND; MANAGEMENT; EXPRESSION;
D O I
10.1007/s12020-016-0919-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recently, it has been suggested that thyrotropin (TSH) concentration can be used as a marker for prediction of thyroid malignancy. In this study, we aimed to investigate the association between TSH levels and prediction of malignancy in euthyroid patients with different Bethesda categories. The data of 1433 euthyroid patients with 3206 thyroid nodules who underwent thyroidectomy were screened retrospectively. The preoperative cytology results, thyroid function tests, thyroid autoantibodies, and presence of histopathological Hashimoto's thyroiditis (HT) were recorded. Of the 1433 patients, 585 (40.8 %) had malignant and 848 (59.2 %) had benign histopathology. Malignant group had smaller nodule size, elevated TSH levels, and higher rate of presence of HT compared to benign group (p < 0.001, all). Cytology results of 3206 nodules were as follows: 832 nondiagnostic (ND), 1666 benign, 392 atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS), 68 follicular neoplasm/suspicious for follicular neoplasm (FN/SFN), 133 suspicious for malignancy (SM), and 115 malignant. Both SM and malignant cytology groups had higher TSH levels than other 4 Bethesda categories (p < 0.05, all). Benign cytology group had significantly lower TSH levels compared to other cytology groups (p < 0.05, all). Patients with malignant final histopathology in ND and AUS/FLUS cytology groups had significantly higher TSH levels compared to patients with benign final histopathology (p < 0.05, all). Moreover, TSH levels showed to increase from Bethesda categories II to VI. In addition to cytology, higher TSH levels can be used as a supplementary marker in prediction of malignancy in certain Bethesda categories.
引用
收藏
页码:520 / 529
页数:10
相关论文
共 49 条
[1]  
[Anonymous], ROYAL COLL PHYS BRIT
[2]   CANCER RISK IN PATIENTS WITH COLD THYROID-NODULES - RELEVANCE OF IODINE INTAKE, SEX, AGE, AND MULTINODULARITY [J].
BELFIORE, A ;
LAROSA, GL ;
LAPORTA, GA ;
GIUFFRIDA, D ;
MILAZZO, G ;
LUPO, L ;
REGALBUTO, C ;
VIGNERI, R .
AMERICAN JOURNAL OF MEDICINE, 1992, 93 (04) :363-369
[3]   Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration [J].
Boelaert, K. ;
Horacek, J. ;
Holder, R. L. ;
Watkinson, J. C. ;
Sheppard, M. C. ;
Franklyn, J. A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4295-4301
[4]   High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies [J].
Boi, F ;
Lai, ML ;
Marziani, B ;
Minerba, L ;
Faa, G ;
Mariotti, S .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (05) :637-642
[5]   HUMAN THYROTROPIN RECEPTOR GENE - EXPRESSION IN THYROID-TUMORS AND CORRELATION TO MARKERS OF THYROID DIFFERENTIATION AND DEDIFFERENTIATION [J].
BRABANT, G ;
MAENHAUT, C ;
KOHRLE, J ;
SCHEUMANN, G ;
DRALLE, H ;
HOANGVU, C ;
HESCH, RD ;
VONZURMUHLEN, A ;
VASSART, G ;
DUMONT, JE .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1991, 82 (01) :R7-R12
[6]   Predictors of Malignancy in Patients with Cytologically Suspicious Thyroid Nodules [J].
Castro, M. Regina ;
Espiritu, Rachel P. ;
Bahn, Rebecca S. ;
Henry, Michael R. ;
Gharib, Hossein ;
Caraballo, Pedro J. ;
Morris, John C. .
THYROID, 2011, 21 (11) :1191-1198
[7]   TSH measurement is not an appropriate screening test for autonomous functioning thyroid nodules: a retrospective study of 368 patients [J].
Chami, Rayan ;
Moreno-Reyes, Rodrigo ;
Corvilain, Bernard .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 170 (04) :593-599
[8]   Thyroid Nodule with Benign Cytology: Is Clinical Follow-Up Enough? [J].
Choi, Yoon Jung ;
Jung, Inkyung ;
Min, Sung Ji ;
Kim, Hye Jung ;
Kim, Ji-hoon ;
Kim, Soojin ;
Park, Jeong Seon ;
Shin, Jung Hee ;
Sohn, Yu-Mee ;
Yoon, Jung Hyun ;
Kwak, Jin Young .
PLOS ONE, 2013, 8 (05)
[9]  
Cibas ES, 2009, THYROID, V19, P1159, DOI [10.1089/thy.2009.0274, 10.1309/AJCPPHLWMI3JV4LA]
[10]   Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer [J].
Cooper, David S. ;
Doherty, Gerard M. ;
Haugen, Bryan R. ;
Kloos, Richard T. ;
Lee, Stephanie L. ;
Mandel, Susan J. ;
Mazzaferri, Ernest L. ;
McIver, Bryan ;
Pacini, Furio ;
Schlumberger, Martin ;
Sherman, Steven I. ;
Steward, David L. ;
Tuttle, R. Michael .
THYROID, 2009, 19 (11) :1167-1214